top of page

Professor Katsunori YANAGIHARA

柳原  克紀

MD, PhD

TMGH Modules

  • Medical Microbiology

Background

  • Infectious diseases

  • Clinical microbiology

  • Laboratory Medicine

Affiliations

Department of Laboratory Medicine, Graduate School of Biomedical Sciences,

Nagasaki University

Prof. Katsunori YANAGIHARA

​

        095-819-7574

Facebook

Prof. Katsunori YANAGIHARA

​

        095-819-7574

Website

Research Areas

  • Infectious diseases

  • Clinical microbiology

  • Laboratory Medicine

Disciplines

  • Bacteriology

Other Areas of Interest

  • Drug resistant pathogen

Countries/Regions

  • Republic of the Philippines

Selected Publications

2
3
4
5
1

Clinical application of a ligation-independent pathway of multiplex ligation-dependent probe amplification for the determination of quinolone susceptibility of Streptococcus pneumoniae.

Uno N, Araki N, Kaku N, Kosai K, Hasegawa H, Yanagihara K. J Microbiol Methods. 128:13-5, 2016.

Efficacy and pharmacokinetics of ME1100, a novel optimized formulation of arbekacin for inhalation, compared with amikacin in a murine model of ventilator-associated pneumonia caused by Pseudomonas aeruginosa.

Kaku N, Morinaga Y, Takeda K, Kosai K, Uno N, Hasegawa H, Miyazaki T, Izumikawa K, Mukae H, Yanagihara K. J Antimicrob Chemother. 2016 Dec 20. pii: dkw517. doi: 10.1093/jac/dkw517. [Epub ahead of print]

Antimicrobial and immunomodulatory effects of tedizolid against methicillin-resistant Staphylococcus aureus in a murine model of hematogenous pulmonary infection.

Kaku N, Morinaga Y, Takeda K, Kosai K, Uno N, Hasegawa H, Miyazaki T, Izumikawa K, Mukae H, Yanagihara K. Int J Med Microbiol. 2016 Sep;306(6):421-8

Multicenter evaluation of the Verigene Gram-negative blood culture nucleic acid test for rapid detection of bacteria and resistance determinants in positive blood cultures.

Uno N, Suzuki H, Yamakawa H, Yamada M, Yaguchi Y, Notake S, Tamai K, Yanagisawa H, Misawa S, Yanagihara K. Diagn Microbiol Infect Dis. 2015 Dec;83(4):344-8

Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology in 2010: General view of the pathogens' antibacterial susceptibility.

Yanagihara K, Kadota J, Aoki N, Matsumoto T, et al. J Infect Chemother. 2015 Jun;21(6):410-20

bottom of page